News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Jonathan Licht: How KDM6A controls MHC-I and II expression in multiple myeloma cells
Jonathan Licht/X
Oct 9, 2024, 16:24

Jonathan Licht: How KDM6A controls MHC-I and II expression in multiple myeloma cells

Jonathan Licht, Director of the UF Health Cancer Center, shared a post on X:

“Our paper on how tumor suppressor KDM6A controls MHC-I and II expression in multiple myeloma cells is out in print in Blood Journal.

KDM6A loss can be ameliorated by treatment of cells with an HDAC3 inhibitor, restoring MHC expression.”

KDM6A controls immunogenicity in MM

Authors: Jerome Moreaux.

Jonathan Licht: How KDM6A controls MHC-I and II expression in multiple myeloma cells

 

Blood Journal cancer cancer awareness cancer care Cancer research fight against cancer Global fight against cancer Jerome Moreaux Jonathan Licht Myeloma OncoDaily Oncology
Special Coverage
Blog
May 9, 2025, 09:39
Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025
Blog
May 9, 2025, 09:37
Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session
Blog
May 9, 2025, 09:29
ESO - M2ICOS Project Launches Fellowship Program to Support Oncology Training and Mobility in the EU
Science
May 9, 2025, 09:22
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Drugs
May 9, 2025, 09:15
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Drugs
May 9, 2025, 08:47
Jonathan Pachter: FDA Grants Accelerated Approval for 1st Targeted Therapy in KRAS-Mutant LGSOC
Blog
May 9, 2025, 08:15
Parminder Singh: Grand Rounds at Mayo Clinic
Science
May 9, 2025, 08:02
Ashish Kamat: Predictive Value of AI Histologic Biomarker CHAI in NMIBC Treatment
Drugs
May 9, 2025, 07:54
Rahul Banerjee: Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma
Blog
May 9, 2025, 07:41
Eric Singhi: First-Year Fellow’s Graduation from the Singhi Clinic
Science
May 9, 2025, 07:24
Elizabeth McKenna: Study on Early- and Older-Onset Cancer Trends in the U.S. by Meredith Shiels and colleagues
Drugs
May 9, 2025, 07:19
Jenny Seligmann: FOxTROT 5 Opens in the UK – New immunotherapy trial for older colon cancer patients